BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lyssiotis CA, Nagrath D. Metabolic Reprogramming and Vulnerabilities in Cancer. Cancers (Basel) 2019;12:E90. [PMID: 31905922 DOI: 10.3390/cancers12010090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang L, She R, Zhu J, Lu J, Gao Y, Song W, Cai S, Wang L. Novel lipometabolism biomarker for chemotherapy and immunotherapy response in breast cancer. BMC Cancer 2022;22:1030. [PMID: 36182903 DOI: 10.1186/s12885-022-10110-8] [Reference Citation Analysis]
2 Gómez-Cebrián N, Poveda JL, Pineda-Lucena A, Puchades-Carrasco L. Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches. Cancers (Basel) 2022;14:596. [PMID: 35158864 DOI: 10.3390/cancers14030596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Firdous S, Abid R, Nawaz Z, Bukhari F, Anwer A, Cheng LL, Sadaf S. Dysregulated Alanine as a Potential Predictive Marker of Glioma-An Insight from Untargeted HRMAS-NMR and Machine Learning Data. Metabolites 2021;11:507. [PMID: 34436448 DOI: 10.3390/metabo11080507] [Reference Citation Analysis]
4 Aquila S, Santoro M, Caputo A, Panno ML, Pezzi V, De Amicis F. The Tumor Suppressor PTEN as Molecular Switch Node Regulating Cell Metabolism and Autophagy: Implications in Immune System and Tumor Microenvironment. Cells 2020;9:E1725. [PMID: 32708484 DOI: 10.3390/cells9071725] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
5 Cohen EB, Geck RC, Toker A. Metabolic pathway alterations in microvascular endothelial cells in response to hypoxia. PLoS One 2020;15:e0232072. [PMID: 32645038 DOI: 10.1371/journal.pone.0232072] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]